MedMen To Sell Florida Operations, Plans To Launch Global Trademark Licensing Program

Cannabis retailer MedMen Enterprises Inc. MMEN MMNFF is selling its Florida assets to Florida-based private company Green Sentry Holdings LLC for $83 million.

Deal Details

The cash deal includes the sale of substantially all of MedMen’s Florida-based assets, including its license, dispensaries, inventory and cultivation operations.

Additionally, the company agreed to license its trademarks in the state for a two-year period, subject to termination rights, for a quarterly revenue-based fee.

The transaction is subject to customary closing conditions, including applicable regulatory approvals.

The deal is expected to close in late April or early May 2022, pending the receipt of all required contractual consents and governmental approvals including the requisite change of ownership approval from the Florida Office of Medical Marijuana Use.

Hyperion Capital Inc. provided a fairness opinion to the special committee of the board of directors of MedMen.

Management Commentary

“As MedMen continues to transform its business model and position itself for future growth, our go-forward strategy is going to include an asset-light model that enables us to leverage the power and strength of the MedMen brand,” Michael Serruya, MedMen’s chairman and interim CEO, said. “We feel confident this model will deliver strong financial results and opportunities for growth across many states and will continue to identify trademark licensing opportunities that will introduce the MedMen brand and retail experience to other markets across the United States and internationally.”

Photo: Courtesy of Chris Liverani on Unsplash

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewsPenny StocksAsset SalesMarketsMichael Serruyaretail
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.